Target intelligence / Profile preview

Eukaryotic cytoplasmic ribosome 60S subunit, E site (60S E-site)

Target
60S E-site
Molecular classification
Ribonucleoprotein, Ribosome
01

Overview

The Eukaryotic cytoplasmic ribosome 60S subunit, E site (exit site) is a critical functional region within the large ribosomal subunit responsible for the release of deacylated tRNA during protein synthesis (Garreau de Loubresse et al., 2014). During the elongation phase of translation, the ribosome moves along the mRNA, and the tRNA that has donated its amino acid to the growing polypeptide chain shifts from the P-site to the E-site before being ejected (Budkevich et al., 2011). This site is composed of both ribosomal RNA (rRNA) and ribosomal proteins, providing a specific structural pocket that coordinates with the tRNA's CCA-end. While the E-site is essential for maintaining the reading frame and ensuring efficient translocation, it also serves as a target for various small-molecule inhibitors. For example, glutarimide antibiotics like cycloheximide bind specifically to the 60S E-site, blocking the translocation of tRNA and effectively halting protein synthesis (Schneider-Poetsch et al., 2010). Although many E-site inhibitors are too toxic for systemic human use due to their impact on host translation, they are invaluable tools in molecular biology and serve as templates for developing selective antifungal agents.

Other names
Large ribosomal subunit exit site60S exit siteRibosomal E-siteEukaryotic 60S E-site
02

Mechanism of action

Inhibitors bind to the E-site of the 60S subunit, sterically hindering the translocation of deacylated tRNA from the P-site to the E-site or preventing its release, thereby arresting the elongation phase of protein translation.

03

Biological functions

Protein synthesisTranslation elongationtRNA translocationDeacylated tRNA release
04

Disease associations

InfectionCancer
05

Safety considerations

High systemic toxicityLack of selectivity between host and pathogen eukaryotic ribosomesInhibition of essential cellular protein synthesisNarrow therapeutic index
06

Interacting drugs

Cycloheximide

3 more in the full profile.

07

Biomarkers

Global protein synthesis ratePolysome profilePuromycin incorporation levels

Beyond the preview

Go deeper on Eukaryotic cytoplasmic ribosome 60S subunit, E site (60S E-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic cytoplasmic ribosome 60S subunit, E site (60S E-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call